Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Affymetrix Axiom® Strawberry Genotyping Array

Published: Wednesday, October 23, 2013
Last Updated: Tuesday, October 22, 2013
Bookmark and Share
Delivers automated analysis for high-resolution genome scanning of octoploid strawberry.

Affymetrix, Inc. has announced the launch of Axiom Strawberry Genotyping Array (also called International Strawberry 90K SNP array or IStraw90), the only solution that successfully enables high-resolution genotyping and fully automated data analysis of the octoploid strawberry genome.

This 90,000 SNP array will enable complex trait research and set the stage for multi-trait, marker-assisted breeding of the cultivated garden strawberry (Fragaria × ananassa).

The cultivated garden strawberry is an allo-octoploid with a chromosome number of 2n=8x=56. While there are other genotyping technologies available to scan genomes of agricultural species at high resolution, most have been designed for diploids.

With Affymetrix’ advanced bioinformatics and innovative design strategy, Axiom Genotyping Solution provides genome-wide genotyping and accurately calls the genotypes of both diploid and polyploid species. This technology has already been successfully applied to complex genomes such as maize, rose, wheat, trout, and salmon.

Axiom Strawberry Genotyping Array was designed through a public-private partnership between Affymetrix and the International RosBREED SNP Consortium (IRSC), an arm of the "RosBREED" project dedicated to the genetic improvement of rosaceous crops.

The RosBREED team including Genotyping Team Leader Nahla Bassil (USDA-ARS, Corvallis), Demonstration Breeder Tom Davis (University of New Hampshire geneticist), and Pedigree-Based Analysis Team Leader Eric van de Weg (Wageningen University & Research Center) partnered with the Affymetrix array design and bioinformatics teams to devise SNP selection and data analysis strategies.

RosBREED has announced the availability of the array through its September 2013 newsletter. Preliminary results from the array were presented at the 2013 annual conference of the American Society for Horticultural Science.

“IStraw90 gives us the capability to create high-resolution genetic maps of the strawberry genome and work towards enabling marker-assisted breeding for strawberry breeders worldwide”, stated Nahla Bassil. “The International RosBREED SNP consortium has been working towards enabling discovery and validation of valuable trait loci. IStraw90 will facilitate many of RosBREED’s goals and expedite marker-assisted breeding in strawberry.”

“The successful design and analysis of the data from the allo-octoploid strawberry genome was possible only because of the expertise, commitment, and collaborative efforts of the Axiom myDesign custom array, bioinformatics, and product support teams within Affymetrix,” stated Eric van de Weg. “It is awesome to have the tools to construct such high marker-density maps generated in such a short time. We expect this array to be a valuable resource for genome-wide analysis and marker-assisted breeding in many American, European and other breeding programs.”

“Genotyping the octoploid strawberry genome demonstrates the power and precision of the Axiom Genotyping platform to type genetic variants within complex genomes,” said Andy Last, Executive Vice President of the Genetic Analysis Business Unit at Affymetrix, “The array design process and updates to the automated analysis software used with Axiom Strawberry Genotyping Array are significant milestones for our platform because they enable the worldwide plant and animal genotyping community to leverage the Axiom myDesign customization process and analysis software to genotype even more species of interest.”

Axiom Strawberry Genotyping Array will complement the catalog of Axiom Agrigenomics Genotyping Arrays that are available for multiple species, including bovine, chicken, and buffalo.

These products have been used for genome-wide association studies, quantitative trait locus mapping, genome mapping, and breeding activities that make use of marker-assisted selection and genomic selection.

As scientists make progress in decoding genomes of various plants, animals, and fish using next-generation sequencing platforms, they can advance their research and commercial objectives by translating those discoveries to routine applications on the Axiom Genotyping platform.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Affymetrix and Athletigen Partner
Partnership agreement to advance genetics in human athletic performance.
Thursday, October 29, 2015
Affymetrix and Luminex Announce Distribution Agreement
Agreement for multiplexed assay instrument platform.
Friday, October 16, 2015
Green Super Rice Project Selects Affymetrix Genotyping Platform for Developing New Rice Varieties
The Green Super Rice (GSR) project includes building a highly efficient genotyping platform for the large-scale molecular breeding activities within the international rice research community.
Tuesday, September 22, 2015
Affymetrix, BioRealm, RUCDR Ally
Affymetrix, BioRealm, and RUCDR Infinite Biologics today announced a strategic alliance to genotype the National Institute of Drug Abuse biorepository.
Wednesday, July 08, 2015
Affymetrix Acquires Assets of Eureka Genomics
Aquisition will enable provision of high throughput and economical crop and animal genotyping.
Thursday, May 14, 2015
CollabRx, Affymetrix To Develop Analytical Tools For Integrated Clinical Cancer Panels
The overall objective of the partnership is to provide scientific knowledge for biomarker CNV profiles in cancer.
Wednesday, April 16, 2014
University of Bristol Collaborates with Affymetrix on Genotyping Arrays
Results from the array presented at the 2014 Plant and Animal Genome conference.
Wednesday, January 15, 2014
Affymetrix Reports 2013 First Quarter Results
Affymetrix, Inc. reported its operating results for the three months ended March 31, 2013.
Wednesday, May 01, 2013
Affymetrix and BioDiscovery Announce Software for Analysis of Whole Genome Copy Number Data
Generated from FFPE solid tumor samples for accelerating cancer translational research.
Thursday, April 11, 2013
Ingenuity Systems and Affymetrix Partner
Companies collaborate to eliminate microarray expression analysis bottleneck.
Monday, April 08, 2013
Affymetrix Announces Collaboration with Centre for Proteomic and Genomic Research (CPGR)
CPGR will provide gene expression and Axiom genotyping services to African researchers using GeneTitan® Multi-Channel (MC) Instrument.
Tuesday, November 20, 2012
Affymetrix and Singapore-based Start-up PathGEN Dx Sign Partnership
Agreement for diagnostic test development for pathogen detection.
Monday, August 27, 2012
Affymetrix Completes Acquisition of eBioscience Holding Company, Inc.
Acquisition expands Affymetrix’s addressable markets by more than $2.5 billion per year.
Thursday, June 28, 2012
Affymetrix Announces Proposed $105 Million Offering of Convertible Senior Notes Due 2019
Company expects to grant an option to purchase up to $10 million aggregate principal amount of additional notes.
Thursday, June 21, 2012
Affymetrix Announces Research Collaboration with MGH
Collaboration and licensing agreement to validate and develop new oncology biomarker tests.
Thursday, June 07, 2012
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Promising Drug Combination for Advanced Prostate Cancer
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
A Cellular Symphony Responsible for Autoimmune Disease
Broad Institute researchers have used a novel approach to increase our understanding of the immune system as a whole.
When it Comes to Breast Cancer, Common Pigeon is No Bird Brain
If pigeons went to medical school and specialized in pathology or radiology, they’d be pretty good at distinguishing digitized microscope slides and mammograms of normal vs. cancerous breast tissue, a new study has found.
Editing of LIMS Data Made Faster and More Efficient in Matrix Gemini
The latest version of the Matrix Gemini LIMS (Laboratory Information Management System) from Autoscribe Informatics now provides faster and more efficient editing of LIMS data by eliminating the need for a second editing screen.
University of Edinburgh, Selcia Achieve Key Milestones in Drug Development Program
Scientists from the University of Edinburgh, working with Selcia, have successfully passed the 20-month milestone targets of a 30-month Wellcome Trust SDDi £2.5 million project to design novel treatments for sleeping sickness.
Red Clover Genome to Help Restore Sustainable Farming
The Genome Analysis Centre (TGAC) in collaboration with IBERS, has sequenced and assembled the DNA of red clover to help breeders improve the beneficial traits of this important forage crop.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos